AFT Pharmaceuticals Limited (AFT.NZ)
NZD 2.64
(1.54%)
NZD 2.64
(1.54%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 88.27 Million NZD | 22.32% |
| 2023 | 72.16 Million NZD | 17.73% |
| 2022 | 61.29 Million NZD | 26.39% |
| 2021 | 48.49 Million NZD | 1.23% |
| 2020 | 47.9 Million NZD | 18.37% |
| 2019 | 40.47 Million NZD | 19.04% |
| 2018 | 34 Million NZD | 31.59% |
| 2017 | 25.84 Million NZD | 21.64% |
| 2016 | 21.24 Million NZD | 0.4% |
| 2015 | 21.15 Million NZD | 4.07% |
| 2014 | 20.33 Million NZD | 15.28% |
| 2013 | 17.63 Million NZD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 17.96 Million NZD | -59.44% |
| 2024 Q2 | 35.93 Million NZD | 100.0% |
| 2024 Q4 | 26.16 Million NZD | 0.0% |
| 2024 Q3 | 26.16 Million NZD | -27.18% |
| 2024 FY | 88.27 Million NZD | 22.32% |
| 2023 Q3 | 22.15 Million NZD | -22.76% |
| 2023 Q2 | 28.67 Million NZD | 100.0% |
| 2023 FY | 72.16 Million NZD | 17.73% |
| 2023 Q4 | 44.3 Million NZD | 100.0% |
| 2023 Q1 | 14.33 Million NZD | -59.11% |
| 2022 Q1 | 13.35 Million NZD | -53.0% |
| 2022 FY | 61.29 Million NZD | 26.39% |
| 2022 Q4 | 35.07 Million NZD | 100.0% |
| 2022 Q3 | 17.53 Million NZD | -34.34% |
| 2022 Q2 | 26.7 Million NZD | 100.0% |
| 2021 Q2 | 20.33 Million NZD | 100.0% |
| 2021 Q3 | 14.2 Million NZD | -30.14% |
| 2021 Q4 | 28.4 Million NZD | 100.0% |
| 2021 FY | 48.49 Million NZD | 1.23% |
| 2021 Q1 | 10.16 Million NZD | -61.41% |
| 2020 Q1 | 10.67 Million NZD | -5.46% |
| 2020 Q2 | 20.82 Million NZD | 95.07% |
| 2020 Q4 | 26.34 Million NZD | 95.74% |
| 2020 Q3 | 13.45 Million NZD | -35.36% |
| 2020 FY | 47.9 Million NZD | 18.37% |
| 2019 Q1 | 9.07 Million NZD | -13.54% |
| 2019 FY | 40.47 Million NZD | 19.04% |
| 2019 Q4 | 11.29 Million NZD | 0.0% |
| 2019 Q3 | 11.29 Million NZD | 24.42% |
| 2019 Q2 | 9.07 Million NZD | 0.0% |
| 2018 FY | 34 Million NZD | 31.59% |
| 2018 Q2 | 7.15 Million NZD | 0.0% |
| 2018 Q3 | 10.49 Million NZD | 46.74% |
| 2018 Q4 | 10.49 Million NZD | 0.0% |
| 2018 Q1 | 7.15 Million NZD | -6.07% |
| 2017 Q1 | 5.38 Million NZD | -77.16% |
| 2017 Q3 | 7.61 Million NZD | 41.42% |
| 2017 FY | 25.84 Million NZD | 21.64% |
| 2017 Q4 | 7.61 Million NZD | 0.0% |
| 2017 Q2 | 5.38 Million NZD | 0.0% |
| 2016 Q2 | 5.19 Million NZD | 0.0% |
| 2016 FY | 21.24 Million NZD | 0.4% |
| 2016 Q4 | 23.57 Million NZD | 257.34% |
| 2016 Q3 | 6.59 Million NZD | 27.11% |
| 2016 Q1 | 5.19 Million NZD | -15.47% |
| 2015 Q4 | 6.14 Million NZD | 0.0% |
| 2015 Q2 | 4.43 Million NZD | 0.0% |
| 2015 FY | 21.15 Million NZD | 4.07% |
| 2015 Q3 | 6.14 Million NZD | 38.37% |
| 2015 Q1 | 4.43 Million NZD | 0.0% |
| 2014 FY | 20.33 Million NZD | 15.28% |
| 2013 FY | 17.63 Million NZD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Greenfern Industries Limited | 279.97 Thousand NZD | -31428.079% |
| Rua Bioscience Limited | -2.42 Million NZD | 3746.866% |